Health & Pharm General

MMJ Group Holdings Ltd (ASX:MMJ) 31 August 2019 Net Tangible Asset Backing

🕔9/12/2019 3:24:30 PM

MMJ Group Holdings Ltd (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) provide the 31 August 2019 Net Tangible Asset Backing.

Read Full Article

Cann Global Limited (ASX:CGB) Asia Distribution Update

🕔9/9/2019 8:19:38 AM

The Board of Cann Global Limited (ASX:CGB) is pleased to provide an update on its recent exclusive distributorship supply contract deal signed with EPCO Foods Co. Ltd in Ho Chi Minh City, Vietnam.

Read Full Article

Cann Global Limited (ASX:CGB) T12 Signs Exclusive Vietnam Distributorship

🕔9/5/2019 9:31:32 AM

The Board of Cann Global Limited (ASX:CGB) is pleased to announce that its T12 Food Division, under managers Sebastian and Samuel Edwards, have just signed an exclusive distributorship contract with EPCO Foods Co. Ltd in Ho Chi Minh City, Vietnam.

Read Full Article

THC Global Group Limited (ASX:THC) Secures 24.6ha Cannabis Cultivation Site

🕔9/5/2019 9:20:12 AM

THC Global Group Limited (ASX:THC) (FRA:9TH) (OTCMKTS:HDRPF) advises that it has secured an agreement to lease a property with 66,000m2 of existing hydroponics greenhouses, and an additional 180,000m2 of agricultural land for the cultivation of medicinal cannabis in Bundaberg, Queensland.

Read Full Article

THC Global Group Limited (ASX:THC) Half Yearly Report and Accounts

🕔9/2/2019 10:25:34 AM

THC Global Group Limited (ASX:THC) operates under a 'Farm to Pharma' pharmaceutical model and is currently delivering high quality medicinal cannabis products to Australian patients through existing access schemes.

Read Full Article

Tim Boreham interviews Anatara CEO Steven Lydeamore for Dr Boreham's Crucible

🕔9/2/2019 10:21:31 AM

Anatara Lifesciences (ASX:ANR) CEO Steve Lydeamore recently spoke with experienced business writer, Tim Boreham, for his Dr Boreham's Crucible column which was published in Biotech Daily on Friday night and then reproduced in Stockhead across the weekend.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Message from the CEO

🕔8/30/2019 1:12:03 PM

The 2018-2019 year has been a year of transition for Anatara Lifesciences (ASX:ANR), having commenced the year with a clear focus on successfully evolving into a human health company, through the pursuit of the burgeoning gastrointestinal health market.

Read Full Article